JP2011502966A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011502966A5 JP2011502966A5 JP2010531330A JP2010531330A JP2011502966A5 JP 2011502966 A5 JP2011502966 A5 JP 2011502966A5 JP 2010531330 A JP2010531330 A JP 2010531330A JP 2010531330 A JP2010531330 A JP 2010531330A JP 2011502966 A5 JP2011502966 A5 JP 2011502966A5
- Authority
- JP
- Japan
- Prior art keywords
- dopamine transporter
- patient
- composition
- ligand
- dementia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98419407P | 2007-10-31 | 2007-10-31 | |
| PCT/US2008/081569 WO2009058851A2 (en) | 2007-10-31 | 2008-10-29 | Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011502966A JP2011502966A (ja) | 2011-01-27 |
| JP2011502966A5 true JP2011502966A5 (https=) | 2012-11-15 |
Family
ID=40591729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010531330A Pending JP2011502966A (ja) | 2007-10-31 | 2008-10-29 | ドーパミントランスポーターレベルを評価することによるレビー小体型認知症の診断およびレビー小体型認知症の処置のモニタリングのための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20100312105A1 (https=) |
| EP (1) | EP2211911A4 (https=) |
| JP (1) | JP2011502966A (https=) |
| CA (1) | CA2703563A1 (https=) |
| WO (1) | WO2009058851A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009040727A2 (en) * | 2007-09-26 | 2009-04-02 | Philips Intellectual Property & Standards Gmbh | Method of differentially diagnosing different types of dementia |
| WO2014152110A1 (en) * | 2013-03-15 | 2014-09-25 | Simon Adam J | Multi-modal pharmaco-diagnostic assessment of brian helath |
| KR20160055103A (ko) | 2013-03-15 | 2016-05-17 | 아담 제이 사이먼 | 뇌 건강의 다중-모드 생리적 자극 및 평가를 위한 시스템 및 시그너처 |
| GB201313291D0 (en) * | 2013-07-25 | 2013-09-11 | Ge Healthcare Ltd | Imaging neurological disease |
| CN104720840A (zh) * | 2015-02-11 | 2015-06-24 | 清华大学深圳研究生院 | 基于多巴胺转运体显像特异性摄取比的半自动量化方法 |
| EP3579887A4 (en) * | 2017-02-10 | 2020-09-16 | Likeminds, Inc. | PROCEDURE FOR IN VIVO MONITORING OF DOPAMINER DISORDERS AND EFFECTIVENESS OF TREATMENT PRODUCTS THEREFORE |
| KR20210034008A (ko) * | 2018-07-18 | 2021-03-29 | 라이크마인즈, 인크. | 뇌로의 화합물의 가속화된 조직 침투를 위한 방법 |
| CN113271985A (zh) * | 2018-08-07 | 2021-08-17 | 悦智有限公司 | 用于诊断多巴胺能和运动障碍的方法 |
| TWI686178B (zh) * | 2019-10-09 | 2020-03-01 | 中原大學 | 自動化定位核子醫學腦部影像紋狀體與計算紋狀體專一性攝取率的方法與系統 |
| WO2021092096A1 (en) * | 2019-11-06 | 2021-05-14 | Likeminds, Inc. | Individualized dosing of radioactive tracers for imaging |
| WO2022240817A1 (en) * | 2021-05-13 | 2022-11-17 | Likeminds, Inc. | Methods of visualizing dopamine transporters |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7081238B2 (en) * | 1995-11-03 | 2006-07-25 | The President And Fellows Of Harvard College | Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level |
| CA2304505A1 (en) * | 1997-09-24 | 1999-04-01 | Nova Molecular, Inc. | Methods for increasing apoe levels for the treatment of neurodegenerative disease |
| EP1311272B1 (en) * | 2000-03-03 | 2006-11-22 | Eisai Co., Ltd. | Novel methods using cholinesterase inhibitors |
| UY27003A1 (es) * | 2000-11-06 | 2002-07-31 | Schering Ag | Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer |
| AU2003291358A1 (en) * | 2002-11-07 | 2004-06-03 | Molecular Geriatrics Corporation | Methods for predicting whether subjects with mild cognitive impairment (mci) will develop alzheimer's disease |
| WO2007022081A2 (en) * | 2005-08-11 | 2007-02-22 | The Brigham And Women's Hospital, Inc. | System and method for performing single photon emission computed tomography (spect) with a focal-length cone-beam collimation |
| CA2628108C (en) * | 2005-11-10 | 2020-01-07 | Certara Usa, Inc. | Method and apparatus for computer modeling the human brain for predicting drug effects |
| DK2012833T3 (en) * | 2006-05-02 | 2015-01-19 | Univ Pennsylvania | RADIOACTIVALLY LABELED DIHYDROTETRABENAZINE DERIVATIVES AND USE THEREOF AS IMAGING AGENTS |
| WO2009040727A2 (en) * | 2007-09-26 | 2009-04-02 | Philips Intellectual Property & Standards Gmbh | Method of differentially diagnosing different types of dementia |
| US8084018B2 (en) * | 2007-10-31 | 2011-12-27 | Alseres Pharmaceuticals, Inc. | Methods for imaging dopamine transporter level |
| JP5603855B2 (ja) * | 2008-04-04 | 2014-10-08 | アビッド レディオファーマシューティカルズ、インク． | 神経変成疾患の放射性薬剤による画像化 |
| AU2009328505B2 (en) * | 2008-12-19 | 2014-11-27 | Panima Pharmaceuticals Ag | Human anti-alpha-synuclein autoantibodies |
| EP2438059A1 (en) * | 2009-06-05 | 2012-04-11 | Link Medicine Corporation | Aminopyrrolidinone derivatives and uses thereof |
| GB0922304D0 (en) * | 2009-12-22 | 2010-02-03 | Ge Healthcare Ltd | Radioiodinated compounds |
-
2008
- 2008-10-29 US US12/739,220 patent/US20100312105A1/en not_active Abandoned
- 2008-10-29 WO PCT/US2008/081569 patent/WO2009058851A2/en not_active Ceased
- 2008-10-29 EP EP08845020A patent/EP2211911A4/en not_active Withdrawn
- 2008-10-29 JP JP2010531330A patent/JP2011502966A/ja active Pending
- 2008-10-29 CA CA2703563A patent/CA2703563A1/en not_active Abandoned
-
2016
- 2016-01-11 US US14/992,510 patent/US20160121003A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011502966A5 (https=) | ||
| Mueller et al. | Tau PET imaging with 18F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study | |
| JP5603855B2 (ja) | 神経変成疾患の放射性薬剤による画像化 | |
| US20100312105A1 (en) | Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level | |
| Zhu et al. | PET/SPECT imaging agents for neurodegenerative diseases | |
| Ossenkoppele et al. | Longitudinal imaging of Alzheimer pathology using [11C] PIB,[18F] FDDNP and [18F] FDG PET | |
| AU2019253837B2 (en) | Imaging neurological disease | |
| Henderson | The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging | |
| JP2014148529A (ja) | ドーパミン輸送体レベルを造影するための方法 | |
| Villemagne et al. | Amyloid imaging | |
| Romano et al. | Florbetapir F 18 for brain imaging of beta-amyloid plaques | |
| US20210162078A1 (en) | Method for diagnosis of dopaminergic and movement disorders | |
| Suppiah et al. | diagnostics MDPI | |
| Chiotis | Molecular imaging of tau in the pathological cascade of Alzheimer’s disease | |
| Coakeley | PET Imaging of Pathological Tau in Progressive Supranuclear Palsy | |
| US20230001026A1 (en) | Pharmaceutical packaging units and methods for concomitant administration of radiotracers | |
| Marek | Preclinical properties and humanin vivoassessment of123I-ABC577 as a novel SPECT agent for imaging amyloid-β | |
| Ponto | Positron Emission Tomography (PET) Imaging: Principles and Potential Role in Understanding Brain Function | |
| Scheinin | EARLY DETECTION OF ALZHEIMER’S DISEASE β-AMYLOID PATHOLOGY | |
| Nair et al. | Amyloid imaging | |
| Justin et al. | SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study | |
| Ossenkoppele et al. | Longitudinal Imaging of Alzheimer Pathology using [P | |
| VLV et al. | Regional variability of imaging biomarkers in autosomal dominant AlzheimerTs disease | |
| JP2003503325A (ja) | 注意欠陥多動性障害（ａｄ−ｈｄ）を決定するためのドーパミントランスポータの映像化 |